These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 2534427
1. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system. Colantonio D, Casale R, Pasqualetti P. Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427 [Abstract] [Full Text] [Related]
2. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising. Burghardt W, Müller R, Diehl KL, Wernze H. Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163 [Abstract] [Full Text] [Related]
3. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. Burghardt W, Wernze H, Diehl KL. Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055 [Abstract] [Full Text] [Related]
4. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P. Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [Abstract] [Full Text] [Related]
5. [ANP in the cirrhotic patient. A clinical contribution]. Parlapiano C, Labellarte A, Primi F, Cervellini P, La Torre F, Paparo SB, Baccarini S, Di Nardo A. Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893 [Abstract] [Full Text] [Related]
6. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance. Sellars L, Shore AC, Mott V, Wilkinson R. Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077 [Abstract] [Full Text] [Related]
7. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide. Trevisani F, Colantoni A, Sica G, Gasbarrini A, D'Intino PE, De Notariis S, De Jaso R, Barbieri A, Morselli A, Gasbarrini G. Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404 [Abstract] [Full Text] [Related]
8. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide]. Gambini G, Fioroni E, Guerra M, Moscatelli A, Valori C. Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847 [Abstract] [Full Text] [Related]
9. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease. Kawasaki H, Uemasu J, Maeda N, Hirayama C, Kobayashi T, Sakurai H. Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881 [Abstract] [Full Text] [Related]
10. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM. Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457 [Abstract] [Full Text] [Related]
11. Urinary excretion of urodilatin in patients with cirrhosis. Saló J, Jiménez W, Kuhn M, Ginès A, Ginès P, Fernández-Esparrach G, Angeli P, Clària J, Bataller R, Arroyo V, Forssmann WG, Rodés J. Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175 [Abstract] [Full Text] [Related]
12. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide. Chen YX, Wang SC, Zhao GN, Tang J, Zhang SX, Tang CS. Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696 [Abstract] [Full Text] [Related]
13. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites. Bonkovsky HL, Hartle DK, Mellen BG, Kutner M, Galambos JT. Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574 [Abstract] [Full Text] [Related]
14. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis. Tulassay T, Tulassay Z, Rascher W. Gastroenterol J; 1990 May; 50(3):140-3. PubMed ID: 2149634 [Abstract] [Full Text] [Related]
15. Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats. Elias AN, Vaziri ND, Domurat ES, Pandian MR, Ansari MA, Yazdani M. J Pharmacol Exp Ther; 1990 Jan; 252(1):438-41. PubMed ID: 2137178 [Abstract] [Full Text] [Related]
16. Increased renin release by exogenous prostaglandin E1 in liver cirrhosis with and without ascites. Uemasu J, Kawasaki H, Hirayama C. Horm Metab Res; 1988 May; 20(5):302-5. PubMed ID: 3042580 [Abstract] [Full Text] [Related]
17. [Neurohumoral activity in liver cirrhosis]. Lazúrová I, Rosochová I, Lichardus B, Trejbal D, Hildebrand T, Tkác I, Machánová Y, Murár J. Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696 [Abstract] [Full Text] [Related]
18. [Aldosterone and renin in liver cirrhosis with ascites]. Vetter H, Vetter W, Beckerhoff R, Glänzer K, Furrer J, Hahn C, Kolloch R, Krück F, Kutz K, Siegenthaler W, Witassek F. Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1755-9. PubMed ID: 929137 [Abstract] [Full Text] [Related]
19. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. Kuiper JJ, Boomsma F, van Buren H, de Man R, Danser AH, van den Meiracker AH. Eur J Clin Invest; 2008 Dec 03; 38(12):939-44. PubMed ID: 19021719 [Abstract] [Full Text] [Related]
20. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. Sansoè G, Silvano S, Mengozzi G, Smedile A, Todros L, Baronio M, Bonardi L, Rizzetto M. Am J Gastroenterol; 2002 Sep 03; 97(9):2383-90. PubMed ID: 12358261 [Abstract] [Full Text] [Related] Page: [Next] [New Search]